#CNBC Merck CEO Rob Davis on FDA approval of Keytruda injection, navigating new vaccine landscape

Merck CEO Rob Davis on FDA approval of Keytruda injection, navigating new vaccine landscape
CNBC’s Angelica Peebles and Merck chairman and CEO Rob Davis join ‘Squawk Box’ to discuss the FDA’s approval of the injectable version of Keytruda, pricing for the new injection, navigating the new vaccine landscape, demand for Merck’s vaccines, future of drug pricing, and more.

Thank you for your support in keeping this website running.💛

View on “Tokyo Trend News”